Autoimmune bullous skin disease
MONDO:0019337An autoimmune disease characterized by blisters on the skin.
Also known as: bullous skin disease, bullous dermatosis
92 clinical trials for this condition and its sub-types, 7 tagged with Autoimmune bullous skin disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Autoimmune bullous skin disease
-
Pemphigus 20 trials · 28 incl. sub-types
6 sub-types
- Pemphigus vulgaris 13 trials Sub-types →
- Pemphigus foliaceus 3 trials · 6 incl. sub-types Sub-types →
- Hailey-Hailey disease 4 trials
- Herpetiform pemphigus 0 trials
- Pemphigoid gestationis 0 trials
- Pemphigus erythematosus 0 trials
-
Bullous pemphigoid 18 trials
-
Mucous membrane pemphigoid 5 trials · 9 incl. sub-types
1 sub-type
- Ocular cicatricial pemphigoid 4 trials
-
Acquired epidermolysis bullosa 3 trials
-
Dermatitis herpetiformis 1 trial
2 sub-types
- Dermatitis herpetiformis, familial 0 trials
- Juvenile dermatitis herpetiformis 0 trials
-
Pemphigoid 1 trial
-
IgA pemphigus 0 trials
-
Anti-p200 pemphigoid 0 trials
-
Linear IgA Dermatosis 0 trials
-
Paraneoplastic pemphigus 0 trials
-
Subcorneal pustular dermatosis 0 trials
Most studied deeper sub-types
-
Insulin ointment shows promise for speeding up wound healing in rare blistering disease
Symptom relief CompletedThis study tested whether applying insulin directly to skin sores helps them heal faster in people with pemphigus vulgaris, a rare autoimmune blistering disease. Twenty patients each had three similar sores treated with either long-acting insulin, short-acting insulin, or a saltw…
Phase 2 • Sponsor: Alexandria University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Study reveals vaccine response in Immune-Compromised patients
Knowledge-focused CompletedThis study looked at how people with autoimmune diseases like multiple sclerosis or blistering skin conditions respond to COVID-19 vaccines while on B-cell depleting therapies. Researchers measured antibody levels and T-cell activity over time to understand vaccine effectiveness …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC